Snowflake Score | |
---|---|
Valuation | 2/6 |
Future Growth | 0/6 |
Past Performance | 0/6 |
Financial Health | 2/6 |
Dividends | 0/6 |
Lifecome Biochemistry Co.,Ltd. Competitors
Price History & Performance
Historical stock prices | |
---|---|
Current Share Price | CN¥12.48 |
52 Week High | CN¥33.00 |
52 Week Low | CN¥11.00 |
Beta | 0.67 |
11 Month Change | 7.12% |
3 Month Change | -7.35% |
1 Year Change | -54.03% |
33 Year Change | 20.46% |
5 Year Change | -9.72% |
Change since IPO | -25.88% |
Recent News & Updates
Shareholder Returns
002868 | CN Biotechs | CN Market | |
---|---|---|---|
7D | 7.6% | -0.4% | 1.1% |
1Y | -54.0% | -29.0% | -20.4% |
Return vs Industry: 002868 underperformed the CN Biotechs industry which returned -29% over the past year.
Return vs Market: 002868 underperformed the CN Market which returned -20.4% over the past year.
Price Volatility
002868 volatility | |
---|---|
002868 Average Weekly Movement | 6.8% |
Biotechs Industry Average Movement | 5.7% |
Market Average Movement | 5.4% |
10% most volatile stocks in CN Market | 8.5% |
10% least volatile stocks in CN Market | 3.6% |
Stable Share Price: 002868 has not had significant price volatility in the past 3 months.
Volatility Over Time: 002868's weekly volatility (7%) has been stable over the past year, but is still higher than 75% of CN stocks.
About the Company
Founded | Employees | CEO | Website |
---|---|---|---|
2003 | 992 | Tanping Lai | www.pclifecome.com |
Lifecome Biochemistry Co.,Ltd. operates as a biopharmaceutical company in China. It offers bacitracin zinc products, colistin sulfate products, probiotics products, bacitracin methylene disalicylate products, biological preservatives, etc.; veterinary drugs; and food preservatives.
Lifecome Biochemistry Co.,Ltd. Fundamentals Summary
002868 fundamental statistics | |
---|---|
Market cap | CN¥1.94b |
Earnings (TTM) | -CN¥262.23m |
Revenue (TTM) | CN¥603.39m |
3.2x
P/S Ratio-7.4x
P/E RatioIs 002868 overvalued?
See Fair Value and valuation analysisEarnings & Revenue
002868 income statement (TTM) | |
---|---|
Revenue | CN¥603.39m |
Cost of Revenue | CN¥733.69m |
Gross Profit | -CN¥130.30m |
Other Expenses | CN¥131.94m |
Earnings | -CN¥262.23m |
Last Reported Earnings
Jun 30, 2024
Next Earnings Date
n/a
Earnings per share (EPS) | -1.69 |
Gross Margin | -21.59% |
Net Profit Margin | -43.46% |
Debt/Equity Ratio | 288.3% |
How did 002868 perform over the long term?
See historical performance and comparison